|
|
 |
| |
 |
Board of Directors |
 |
|
|
|
James R. Murphy
Director and non-executive Chairman of the Board
Mr. Murphy has served as our non-executive Chairman of the Board since the spin-off from Bentley in 2008.
Mr. Murphy was one of Bentley’s directors from 1993 until the spin-off. Mr. Murphy was President of Bentley
from September 1994 until August 2005, was named Chief Executive Officer and Chairman of the Board in 1995.
Prior to rejoining Bentley, Mr. Murphy served as Vice President of Business Development at MacroChem
Corporation, a publicly owned pharmaceutical and drug delivery company, from March 1993 through September
1994. From September 1992 until March 1993, Mr. Murphy previously served as a consultant in the pharmaceutical
industry and he spent 14 years in pharmaceutical research and product development with SmithKline Corporation
and in international business development with contract research and consulting laboratories. Mr. Murphy
received a B.A. in Biology from Millersville University. |
|
|
John A. Sedor
Director,
President and Chief Executive Officer
Mr. Sedor was elected to our board of directors in 2009 and has been our President and Chief Executive Officer since the spin-off
from Bentley in 2008. Mr. Sedor was President of Bentley from 2005 until the spin-off. From 2001 to May 2005,
he was President and CEO of Sandoz, Inc. (a division of Novartis AG). From 1998-2001 Mr. Sedor was President and
Chief Executive Officer at Verion, Inc., a drug delivery company. Previously, Mr. Sedor served as President and
Chief Executive Officer at Centeon, LLC, a joint venture between two major multinational corporations, Rhône-Poulenc
Rorer and Hoechst AG. Previously, Mr. Sedor served as Executive Vice President at Rhône-Poulenc Rorer, Revlon
Health Care and Parke-Davis. Mr. Sedor holds a Bachelor of Science degree in Pharmacy/Chemistry from Duquesne
University, and has studied strategic marketing at both Northwestern University’s Kellogg Graduate School of
Management and Harvard Business School. He has also attended Harvard’s Executive Forum. |
|
|
Michael McGovern
Director
Mr. McGovern has served as one of our directors since the spin-off from Bentley. Mr. McGovern served as a Bentley director from 1997 until the spin-off and was named Vice Chairman of Bentley in October 1999. Mr. McGovern serves as President of McGovern Enterprises, a provider of corporate and financial consulting services, which he founded in 1975. Mr. McGovern is Chairman of the Board of Training Solutions Interactive, Inc., Chairman of the Board of Teacher Research Network, LLC, Vice Chair of L2C Corporation, a Director on the corporate board of the Reynolds Development Company, a Director of Eclipse Aerospace, Inc., a Director of Community & Southern Bank, Inc. and a Director of Community & Southern Bank Holdings, Inc. Mr. McGovern received a B.S. and M.S. in accounting and his Juris Doctor from the University of Illinois. Mr. McGovern is a Certified Public Accountant. |
|
|
John W. Spiegel
Director
Mr. Spiegel has served as one of our directors since the spin-off from Bentley. Mr. Spiegel served as a Bentley director from 2002 until the spin-off. Mr. Spiegel served as Vice Chairman and Chief Financial Officer of SunTrust Banks, Inc. from August 2000 until he retired as Chief Financial Officer in August 2004 and as Vice Chairman in 2005. Prior to August 2000, Mr. Spiegel was an Executive Vice President and Chief Financial Officer of SunTrust Banks since 1985. Mr. Spiegel also serves on the Board of Directors of Rock-Tenn Company, S1 Corporation, Colonial Properties Trust and formerly served on the Board of Directors of Homebanc Corp. Mr. Spiegel is a member of the Dean’s Advisory Council of the Goizueta Business School at Emory University. Mr. Spiegel is also a member of the board of directors of Community & Southern Bank Holdings, Inc. and chairman of its banking subsidiary. Mr. Spiegel received an MBA from Emory University. |
|
|
Robert Forrester
Director
Robert Forrester was appointed to our board of directors effective April 30,
2010. Mr. Forrester is the Chief Operating Officer of FORMA Therapeutics, Inc.,
a private pharmaceutical development company. Before joining FORMA, Mr.
Forrester was the Interim President and Chief Executive Officer, and Chief
Financial Officer of CombinatoRx (NASDAQ:CRXX), a pharmaceutical development
company, from 2004 until 2010. Prior to joining CombinatoRx, Mr. Forrester
served as Senior Vice President, Finance and Corporate Development at Coley
Pharmaceutical Group (acquired by Pfizer, Inc.), a pharmaceutical company, from
2000 to 2003. From 1994 to 2000, Mr. Forrester was a managing director of the
Proprietary Investment Group at MeesPierson, part of the Fortis Group, a
banking, insurance, and investment management company. Prior to MeesPierson, Mr.
Forrester worked for BZW, UBS, & Clifford Chance. He is a member of the Board of
Directors of Myriad Pharmaceuticals (NASDAQ:MYRX), Atlantic Healthcare, Rhapsody
Biologics and MoMelan Technologies. He holds a LL.B. from Bristol University. |
|
|
|
|
|
